Atria Investments’s VictoryShares US EQ Income Enhanced Volatility Wtd ETF CDC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,552
Closed -$365K 1997
2025
Q1
$365K Sell
5,552
-17
-0.3% -$1.09K ﹤0.01% 1509
2024
Q4
$349K Buy
5,569
+51
+0.9% +$3.31K ﹤0.01% 1514
2024
Q3
$359K Buy
5,518
+37
+0.7% +$2.29K ﹤0.01% 1516
2024
Q2
$321K Buy
+5,481
New +$322K ﹤0.01% 1550
2023
Q3
Sell
-91,862
Closed -$5.29M 847
2023
Q2
$5.29M Sell
91,862
-1,043
-1% -$61.4K 0.1% 252
2023
Q1
$5.63M Buy
92,905
+590
+0.6% +$36.9K 0.11% 230
2022
Q4
$5.73M Buy
92,315
+21,353
+30% +$1.33M 0.12% 220
2022
Q3
$4.21M Buy
70,962
+24,901
+54% +$1.65M 0.09% 271
2022
Q2
$3.04M Buy
+46,061
New +$3.22M 0.06% 372

Other funds holding CDC

Atria Investments's CDC Position: Q2 2025 in Review

Atria Investments sold out of VictoryShares US EQ Income Enhanced Volatility Wtd ETF (CDC) in Q2 2025, closing a stake of 5,552 shares — an estimated $365K sold.

Atria Investments first reported a position in CDC in Q2 2022 and held it in 9 quarters. The position peaked at $5.73M in Q4 2022. 97 funds tracked by Wall St. Rank hold CDC as of Q2 2025.

  • Atria Investments reported no remaining VictoryShares US EQ Income Enhanced Volatility Wtd ETF position as of Q2 2025 after selling out during the quarter.
  • Atria Investments sold 5,552 VictoryShares US EQ Income Enhanced Volatility Wtd ETF shares in Q2 2025, an estimated $365K.
  • Atria Investments first reported a position in VictoryShares US EQ Income Enhanced Volatility Wtd ETF in Q2 2022 and held it in 9 quarters.
  • Atria Investments's VictoryShares US EQ Income Enhanced Volatility Wtd ETF position peaked at $5.73M in Q4 2022.
  • 97 funds tracked by Wall St. Rank held VictoryShares US EQ Income Enhanced Volatility Wtd ETF as of Q2 2025.

Based on Atria Investments's 13F filing for Q2 2025, filed 4 Aug 2025.